INS and gestational diabetes: A randomized, controlled trial assessing HbA1c results in patients with GDM treated with insulin revealed significantly lower HbA1c concentration in the CGM group (CGM group: 5.2 ± 0.4% vs. SMBG group: 5.6 ± 0.6%, p < 0.006) [6].